Acronym |
  |
Trial Name |
  |
 |
|
Appropriate Blood pressure Control in Diabetes – Part 2 with Valsartan |
 |
|
Aspirin and simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes |
 |
|
Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension |
 |
|
Action to Control Cardiovascular Risk in Diabetes |
 |
|
Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events |
 |
|
Atrial Fibrillation and Congestive Heart Failure |
 |
|
Albumin in Acute Stroke |
 |
|
Australian National Blood Pressure study 2 |
 |
|
Angiotensin II antagonist In Paroxysmal Atrial Fibrillation |
 |
|
Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol 6 – HDL and LDL Treatment Strategies |
 |
|
Aspirin non-responsiveness and Clopidogrel Endpoint Trial |
 |
|
Aortic Stenosis progression Observation: Measuring Effects of Rosuvastatin |
 |
|
Anticoagulation and Risk factors In Atrial fibrillation |
 |
|
Morbidity-mortality Evaluation of the If inhibitor ivabradine in patients with coronary disease and left ventricular dysfunction |
 |
|
Carotid Atorvastatin Study in Hyperlipidemic post-Menopausal women |
 |
|
Compliance and quality of life study comparing once-daily controlled-release carvedilol and twice-daily immediate-release carvedilol in patients with heart failure |
 |
|
Second Chinese Cardiac Study |
 |
|
Comparison of the Effects Noted in the ApoB/ApoA-I ratio Using Rosuvastatin and atorvastatin in patients with acute coronary Syndrome |
 |
|
Controlling Hypertension and Hypotension Immediately Post-Stroke |
 |
|
Clopidogrel to Improve Primary percutaneous coronary intervention in Acute Myocardial Infarction |
 |
|
Combination therapy of hypertension to Prevent cardiovascular Events |
 |
|
Continue Or Stop post-Stroke Antihypertensives Collaborative Study |
 |
|
Clinical Outcomes Utilizing Revascularization and Aggressive Guideline-driven drug Evaluation |
 |
|
Coronary Prevention and Hypertension Research Project |
 |
|
Cardiovascular risk Reduction by Early Anemia Treatment with Epoetin beta |
 |
|
Chronic Renal Insufficiency Cohort |
 |
|
Diabetic Atherosclerosis Prevention by Cilostazol |
 |
|
Early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation Acute Coronary Syndrome |
 |
|
Evaluation of Nifedipine and Cerivastatin On Recovery of Endothelial function II |
 |
|
Ezetimibe and Simvastatin in Hypercholesterolemia Enhances atherosclerosis regression |
 |
|
Efficacy of Nitric Oxide in Stroke |
 |
|
European Risk and Incidence, a Coordinated Analysis |
 |
|
Early Self Controlled Anticoagulation Trial II |
 |
|
Extended Clinical prophylaxis in Acutely Ill Medical patients |
 |
|
Fluvastatin in the therapy of Acute Coronary Syndrome |
 |
|
Finnish Cardiovascular Study |
 |
|
Fosinopril in Dialysis |
 |
|
Follow-Up Serial Infusions Of Nesiritide II |
 |
|
Glucose-Insulin-Potassium Study – 2 |
 |
|
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocradico – Atrial Fibrillation |
 |
|
Hypertension in Diabetes Study |
 |
|
Heart failure revascularisation trial |
 |
|
Hyperglycemia and its Effect after Acute Myocardial infarction on cardiovascular outcomes in patients with Type 2 Diabetes mellitus |
 |
|
High-risk and Population strategy for Occupational Health Promotion |
 |
|
High-density lipoprotein Intervention Trial |
 |
|
Hypertension Objective treatment based on Measurement by Electrical Devices of BP |
 |
|
Heart Outcomes Prevention Evaluation – 2 |
 |
|
Investigation on Colchicine for Acute Pericarditis |
 |
|
Isfahan Healthy Heart Programme |
 |
|
Irbesartan in the Management of Proteinuric patients at high risk for Vascular Events |
 |
|
Improved Reduction of Outcomes: Vytorin Efficacy International Trial |
 |
|
Incipient to Overt: Angiotensin II receptor blocker, Telmisartan, Investigation On type 2 diabetic Nephropathy |
 |
|
Japanese Trial to assess Optimal Systolic blood pressure in elderly hypertensive patients |
 |
|
Effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension |
 |
|
Japan EPA Lipid Intervention Study |
 |
|
|
 |
|
Japanese Rhythm management trial for atrial fibrillation |
 |
|
Kronos Early Estrogen Prevention Study |
 |
|
Korean Health and Genome Study |
 |
|
Lower Extremity Arterial Disease Event Reduction |
 |
|
Action for Health in Diabetes |
 |
|
Melatonin Adjunct in the acute myocardial Infarction treated with Angioplasty |
 |
|
Myocardial Infarction Secondary Prevention Study |
 |
|
Media Intima Thickness Evaluation of Candesartan |
 |
|
Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research |
 |
|
|
 |
|
Prevention by low dose Aspirin of Cardiovascular disease in the Elderly |
 |
|
Paracetamol (Acetaminophen) In Stroke |
 |
|
Randomized Angiotensin receptor antagonist – ACE inhibitor Study |
 |
|
Resource utilization Among Congestive Heart failure |
 |
|
Risk factors, Evaluation of Coronary Calcium and Lifestyle |
 |
|
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycaemia in Diabetes |
 |
|
Reasons for Geographic And Racial Differences in Stroke |
 |
|
Renin-Aldosterone |
 |
|
Randomised Olmesartan And Diabetes Microalbuminuria Prevention |
 |
|
Stop Atherosclerosis in Native Diabetics Study |
 |
|
Shock Inhibition Evaluation with Azimilide |
 |
|
Telmisartan Effectiveness on Left ventricular Mass Reduction |
 |
|
Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure |
 |
|
Thrombolysis in Cardiac Arrest |
 |
|
Veterans Affairs Diabetes Trial |
 |
|
Valsartan Cardio-Renal Protection |
 |
|
Valsartan In Diastolic Dysfunction |
 |
|
Valsartan in elderly Isolated Systolic Hypertension |
 |
|
Women’s Antioxidant Cardiovascular Study |
 |